Zenicor Medical Systems AB (publ)

NGM:ZENI Stock Report

Market Cap: SEK 26.9m

Zenicor Medical Systems Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Mats Palerius

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure21.1yrs
CEO ownership9.0%
Management average tenureno data
Board average tenure20.3yrs

Recent management updates

Recent updates

Here's Why Zenicor Medical Systems (NGM:ZENI) Has A Meaningful Debt Burden

Oct 18
Here's Why Zenicor Medical Systems (NGM:ZENI) Has A Meaningful Debt Burden

With EPS Growth And More, Zenicor Medical Systems (NGM:ZENI) Is Interesting

Jan 31
With EPS Growth And More, Zenicor Medical Systems (NGM:ZENI) Is Interesting

Should You Investigate Zenicor Medical Systems AB (publ) (NGM:ZENI) At kr12.40?

Apr 13
Should You Investigate Zenicor Medical Systems AB (publ) (NGM:ZENI) At kr12.40?

Are Zenicor Medical Systems AB (publ)'s (NGM:ZENI) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?

Feb 17
Are Zenicor Medical Systems AB (publ)'s (NGM:ZENI) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?

CEO

Mats Palerius (63 yo)

21.1yrs

Tenure

Mr. Mats Palerius is a Co-Founder of Zenicor Medical Systems AB (publ) and has been its Chief Executive Officer since March 2003. Mr. Palerius has background in managerial positions within development and...


Board Members

NamePositionTenureCompensationOwnership
Mats Palerius
Co-Founder21.3yrsno data8.96%
SEK 2.4m
Lena Kajland-Wilén
Director9.8yrsno data0.084%
SEK 22.7k
Sonny Norström
Director21.3yrsno data9.41%
SEK 2.5m
Gundars Rasmanis
Director20.3yrsno data3.24%
SEK 870.2k
Hakan Jansson
Chairman of the Board5yrsno data0.055%
SEK 14.9k

20.3yrs

Average Tenure

63yo

Average Age

Experienced Board: ZENI's board of directors are seasoned and experienced ( 20.3 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/04/29 23:19
End of Day Share Price 2024/01/31 00:00
Earnings2024/03/31
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Zenicor Medical Systems AB (publ) is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Oscar StjerngrenDanske Bank